Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura

被引:66
作者
Fabris, F
Tassan, T
Ramon, R
Carraro, G
Randi, ML
Luzzatto, G
Moschino, P
Girolami, A
机构
[1] Univ Padua, Sch Med, Dept Med & Surg Sci, I-35100 Padua, Italy
[2] Padua City Hosp, Div Gen Surg 2, Padua, Italy
关键词
immune thrombocytopenia; splenectomy; predictive factors; age; IVGG;
D O I
10.1046/j.1365-2141.2001.02615.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sixty-one consecutive patients undergoing splenectomy for chronic immune thrombocytopenia were retrospectively evaluated. Platelet response was considered as complete (CR) when platelet count rose to > 100 x 10(9)/ 1, partial (PR) when 30-100 x 10(9)/l or absent (NR) if otherwise. Follow-up (mean time 7.6 years) was possible in 54 patients. Forty-eight patients (88%) had an immediate response to splenectomy (39 CR, 9 PR) whereas six (12%) were NR. Thirty-six responders (67%) had sustained remission (31 CR, 5 PR) without further treatment; thrombocytopenia recurred in 12 patients (33%). The probability curve of continued remission showed a constant relapse-rate during the first 36 months; a further step of relapse was observed beginning 70 months after surgery. The only positive predictive factor for the long-term response to splenectomy was age <40 (P < 0.005). Neither duration of thrombocytopenia nor previous response to medical treatment (steroids and/or intravenous immunoglobulins) were related to splenectomy response.
引用
收藏
页码:637 / 640
页数:4
相关论文
共 12 条
[1]  
CORTELAZZO S, 1991, BLOOD, V77, P31
[2]  
Fabris F, 1997, NEW ENGL J MED, V337, P1088
[3]  
FENAUX P, 1989, EUR J HAEMATOL, V42, P259
[4]   Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology [J].
George, JN ;
Woolf, SH ;
Raskob, GE ;
Wasser, JS ;
Aledort, LM ;
Ballem, PJ ;
Blanchette, VS ;
Bussel, JB ;
Cines, DB ;
Kelton, JG ;
Lichtin, AE ;
McMillan, R ;
Okerbloom, JA ;
Regan, DH ;
Warrier, I .
BLOOD, 1996, 88 (01) :3-40
[5]   Treatment options for chronic idiopathic (immune) thrombocytopenic purpura [J].
George, JN .
SEMINARS IN HEMATOLOGY, 2000, 37 (01) :31-34
[6]   MECHANISMS OF RESPONSE TO TREATMENT IN AUTOIMMUNE THROMBOCYTOPENIC PURPURA [J].
GERNSHEIMER, T ;
STRATTON, J ;
BALLEM, PJ ;
SLICHTER, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (15) :974-980
[7]   LACK OF USEFUL CLINICAL PREDICTORS OF RESPONSE TO SPLENECTOMY IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA [J].
JULIA, A ;
ARAGUAS, C ;
ROSSELLO, J ;
BUENO, J ;
DOMENECH, P ;
OLONA, M ;
GUARDIA, R ;
PETIT, J ;
FLORES, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) :250-255
[8]   High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura [J].
Law, C ;
Marcaccio, M ;
Tam, P ;
Heddle, N ;
Kelton, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (21) :1494-1498
[9]  
Mazzucconi MG, 1999, EUR J HAEMATOL, V62, P219
[10]  
MCMILLAN R, 1994, THROMBOSIS HEMORRHAG, P575